M (continued)
- mRNA
- mRNA-derived prostate cancer vaccine CV9103
- MRSI
- MS 209
- MS Contin
- MS-275
- MSI
- MSir
- MTD
- mTOR
- mTOR kinase inhibitor AZD2014
- mTOR kinase inhibitor AZD8055
- mTOR kinase inhibitor OSI-027
- MTX
- MUC-1
- MUC-1 antigen
- MUC-1 peptide vaccine
- MUC1 peptide-poly-ICLC adjuvant vaccine
- MUC1-KLH conjugate vaccine
- MUC1-KLH vaccine / QS21
M (continued)
- mucin/peptide
- mucinous
- mucinous carcinoma
- Mucomyst
- mucosa
- mucosa-associated lymphoid tissue lymphoma
- mucositis
- mucous membrane
- mucus
- mucus colitis
- muJ591
- Mullerian tumor
- multi-epitope melanoma peptide vaccine
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer